Anticoagulation Clinic Follow-Up System for Saudi Hospitals: From INR Lists to a Hospital-Wide Process
An anticoagulation clinic follow-up system gives a Saudi hospital one searchable list of every patient on warfarin, showing the next INR date, the target range set by the clinician and time in therapeutic range, with automatic recall when a test is overdue. It turns one pharmacist's memory into a process that survives staff turnover and branch transfers.
Key takeaways
- Warfarin quality is measured over time, not per visit: time in therapeutic range (TTR), usually calculated with the Rosendaal method, is the standard quality indicator in the Saudi studies below.
- Published Saudi clinic audits show room to improve: at King Abdulaziz Medical City in Riyadh, 55.6% of 883 INR tests in atrial fibrillation patients were in range, and a Saudi tertiary-hospital audit reported nearly 41% of time spent outside the range.
- Clinic design matters: a Jeddah comparison found higher expanded TTR in a pharmacist-managed clinic than a haematologist-managed one, and a Security Forces Hospital study supports telepharmacy for new warfarin patients.
- The operational basics are a registry, a next-due date, overdue recall, result capture, a TTR dashboard and an escalation list. Clinical rules stay with the clinical lead.

On this page
Why INR follow-up is an operations problem, not only a clinical one
Warfarin works only within a narrow window, and the window is judged over weeks and months. A single in-range INR does not show how the patient spent the days between visits. That is why the Saudi studies calculate TTR, the percentage of time a patient's INR sits inside the target range, using the Rosendaal method, and often treat a TTR of 75% or more as good control.
Saudi audits show why this is hard to sustain. A retrospective study at King Abdulaziz Medical City in Riyadh looked at patients with atrial fibrillation in a pharmacist-run anticoagulation clinic: of 883 INR tests, 55.6% were within range, 27.9% above and 16.5% below. A retrospective cohort at a tertiary hospital (Al Bshabshe et al., 2023) concluded that anticoagulation quality was suboptimal, with nearly 41% of time spent outside the therapeutic range. A Prince Sultan Military Medical City study concluded that a low TTR called for better service quality and attention to factors such as regular visits.
None of this says Saudi clinicians are doing it wrong. It says the work behind the clinical decision, who is due, who is late, who was reached, is where a hospital can add structure.
What Saudi evidence says about the clinic model
Three findings are useful for a hospital deciding how to organise follow-up:
- Who runs the clinic matters. At King Abdulaziz Medical City in Jeddah, a retrospective comparison reported a median expanded TTR of 86.4% in the pharmacist-managed clinic versus 81.2% in the haematologist-managed clinic (p = 0.015), with no significant difference in bleeding and thromboembolic events.
- Remote follow-up can work. A Security Forces Hospital study in Riyadh compared telepharmacy with on-site follow-up for patients starting warfarin for the first time, and reported that telepharmacy can be used without the feared undesirable outcomes, adding that Saudi studies during COVID-19 showed comparable TTR after clinics moved to telehealth.
- The patient side counts. Studies at King Khalid University Hospital in Riyadh and King Fahad Hospital in Qassim examined adherence and satisfaction in relation to INR control, which is a reminder that reminders, education and a reachable clinic are part of the intervention, not an add-on.
What a follow-up system should do
For a hospital group, the system needs six working parts. Each maps to a failure mode you can see in a missed-INR audit.
- An active-warfarin registry. Every patient currently on warfarin, with indication, clinician-set target range and responsible clinic. Without it, no one can say how many patients the hospital is following.
- A next-due date on every patient. The interval is chosen by the clinician. The system's job is to hold it and make it visible.
- Overdue recall. A daily list of patients past due, with the channel used (call, SMS, WhatsApp-style messaging, home visit) and the outcome. Missed contact becomes a recorded event.
- Result capture across sites. INR results from the hospital lab, point-of-care devices and branch labs land in one record, so a patient tested at Branch B is not treated as overdue at Branch A.
- A TTR and process dashboard. Per clinic, per branch and per clinician: TTR, share of patients overdue, days from due date to test, and share reached after recall.
- An escalation list. Out-of-range results and unreachable patients go to a named clinician with a time-stamped outcome.
For the surrounding pieces, see how remote monitoring is organised in remote patient monitoring for hospitals in Saudi Arabia, how chronic cohorts are registered in chronic disease registry software for Saudi hospitals, and how refills are coordinated in hospital pharmacy refill and home delivery.
An illustrative scenario
Consider a hospital group with an anticoagulation clinic at its main campus and INR draws at two satellite branches. A patient on warfarin moves to a branch closer to home. The result is entered in a different system, the main clinic list still shows the previous date, and nobody calls. This is a hypothetical scenario, not a customer case. With a shared registry and cross-branch result capture, the patient stays on one list, the overdue flag fires on the right date, and the recall outcome is recorded for the clinic review.
Which numbers to report to hospital leadership
- TTR by clinic and by branch, with the calculation method stated.
- Percentage of active patients overdue for an INR, and median days overdue.
- Recall success: reached within a set number of days, and not reached.
- Percentage of out-of-range results with a documented clinician action.
- Bleeding and thromboembolic events, reviewed by the clinical lead before any use in marketing or external reporting.
Report process measures and clinical measures separately. A system improves recall and visibility. Clinical outcomes need clinical review and a defined comparison.
Governance, privacy and procurement
Patient lists, contact details and results are personal health data. Ask any vendor where data is hosted, who can see which branch's patients, how consent and contact preferences are recorded, and how Saudi privacy requirements are handled. Our overview of PDPL and data localisation for health SaaS sets out the questions to ask. Insist that the clinic's dosing and escalation rules are configured by your clinical lead, not hard-coded by the vendor.
How CareSync fits
CareSync Network is built for multi-branch hospitals that want one patient record view across sites, with registries, recall workflows and dashboards configured to the hospital's own clinical protocols. If you run or plan an anticoagulation clinic, a short working session can map your current INR process to the six parts above and show where recall and result capture are leaking.
FAQ
What is an anticoagulation clinic?
It is a service, usually led by a pharmacist, physician or haematologist, that monitors patients on anticoagulants such as warfarin, reviews INR results, adjusts treatment according to protocol and arranges the next test and education.
How is time in therapeutic range calculated?
The Saudi studies cited here use the Rosendaal method, which estimates the percentage of time a patient's INR was inside the target range between tests. Your clinical lead should define the target range and the reporting period.
Can warfarin follow-up be done by telepharmacy?
A Security Forces Hospital study in Riyadh found telepharmacy usable for patients starting warfarin for the first time, with further multi-centre research recommended. Whether and how to use it is a clinical governance decision.
How often should INR be checked?
That depends on the patient and the clinical situation, and it is set by the treating clinician and clinic protocol. A follow-up system stores and enforces the interval; it does not choose it.
Should a pharmacist or a physician run the clinic?
Saudi studies compare both models, including a Jeddah study in which the pharmacist-managed clinic had higher expanded TTR. Local staffing, credentialing and protocols decide the right design.
Sources
- PMC7804229 (Prince Sultan Military Medical City, Saudi Med J 2020)
- PMC5034360 (King Abdulaziz Medical City Riyadh, AF anticoagulation control)
- PMC8523325 (King Abdulaziz Medical City Jeddah, pharmacist vs haematologist clinic)
- PMC11629656 (Security Forces Hospital, telepharmacy for warfarin-naive patients)
- PMC5783818 (King Fahad Hospital, Qassim)
- PMC4720013 (King Khalid University Hospital, adherence)
- Al Bshabshe et al., Advances in Biomedical and Health Sciences, 2023 (doaj.org/article/4bb2e566beec45949e039f66a0be0be4).